The mammalian Rho GTPase family currently consists of seven distinct proteins: Rho (A, B, and C isoforms), Rac (1 and 2 isoforms), Cdc42 (Cdc42Hs and G25K isoforms), RhoD, RhoG, RhoE, and TC10. Like other members of the Ras superfamily, Rho proteins act as molecular switches to control cellular processes by cycling between active, GTP-bound and inactive, GDPbound states (Fig. 1). Activation of the GTPase, through GDP-GTP exchange, is promoted by guanine nucleotide exchange factors (GEFs), 1 whereas inactivation (by an intrinsic GTPase activity) is stimulated by GTPase-activating proteins (GAPs). Rho guanine nucleotide dissociation inhibitors (Rho-GDIs) appear to stabilize the inactive, GDP-bound form of the protein. Activated Rho GTPases interact with cellular target proteins or effectors to trigger a wide variety of cellular responses, including the reorganization of the actin cytoskeleton and changes in gene transcription. This review aims to summarize current views of Rho GTPase signaling pathways; for reasons of space, however, this will be limited primarily to mammalian Rho, Rac, and Cdc42. More detailed information can be found elsewhere (1, 2).